Comprehensive Nano - Post Market Clinical Follow-Up Study

NCT ID: NCT03423953

Last Updated: 2025-02-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

194 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-10-30

Study Completion Date

2030-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This data collection project is intended to provide clinical outcomes data to engineering, marketing as well as fulfill the post market surveillance requirements of various regulatory authorities. The study will be a prospective and one-arm.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Comprehensive® Shoulder System with Nano humeral component is a humeral prosthesis system intended for use in total or hemi shoulder arthroplasty surgery. Total shoulder arthroplasty consists of replacement of the humeral head and glenoid. Hemi-arthroplasty consists of replacement of only the humeral head.

This project is a prospective study including one-hundred and fifty (150) anatomic and hemi cases and 44 reverse shoulders collected from up to ten (10) sites. All potential study subjects will be required to participate in the Informed Consent process.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis Avascular Necrosis Rheumatoid Arthritis Revision Correction of Functional Deformity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Anatomic

Patients receiving the Anatomic or Hemi verison of the Comprehensive Nano.

Comprehensive Nano

Intervention Type DEVICE

Patients requiring the Comprehensive Nano shoulder system.

Reverse

Patients who have received the Reverse version of the Comprehensive Nano.

Comprehensive Nano

Intervention Type DEVICE

Patients requiring the Comprehensive Nano shoulder system.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Comprehensive Nano

Patients requiring the Comprehensive Nano shoulder system.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis.
* Rheumatoid arthritis
* Revision where other devices or treatments have failed
* Correction of functional deformity.
* Difficult clinical management problems where other methods of treatment may not be suitable or may be inadequate
* Difficult clinical management problems where other methods of treatment may not be suitable or may be inadequate

Exclusion Criteria

* Infection
* Sepsis
* osteomyelitis
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zimmer Biomet

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paola Vivoda

Role: STUDY_DIRECTOR

Zimmer Biomet

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Privatklinik Leech

Graz, Styria, Austria

Site Status

Kingston General Hospital

Kingston, Ontario, Canada

Site Status

Chonnam National University Hospital

Gwangju, , South Korea

Site Status

Samsung Medical Centre

Seoul, , South Korea

Site Status

University of Liverpool

Liverpool, Merseyside, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria Canada South Korea United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ORTHO.CR.GE2.13

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Maxera Large Cups - Canada
NCT04348968 TERMINATED
Perform Humeral System Study
NCT05067543 RECRUITING
The 3DKnee™ System: A Post-Market Study
NCT00764673 COMPLETED PHASE4
Vivacit-E Post-market Follow-up Study
NCT03226808 ACTIVE_NOT_RECRUITING NA